Beneficient (NASDAQ:BENF – Get Free Report) saw a large decline in short interest in October. As of October 15th, there was short interest totaling 516,945 shares, a decline of 45.6% from the September 30th total of 950,383 shares. Based on an average daily volume of 1,150,374 shares, the days-to-cover ratio is presently 0.4 days. Currently, 12.8% of the shares of the company are short sold.
Wall Street Analyst Weigh In
A number of equities analysts have recently issued reports on the company. Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research note on Monday, September 21st. Wall Street Zen upgraded Beneficient to a “hold” rating in a research note on Saturday, October 24th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.
Read Our Latest Analysis on Beneficient
Beneficient Price Performance
Beneficient stock traded down $0.01 during trading hours on Monday, hitting $0.73. The stock had a trading volume of 33,574 shares, compared to its average volume of 3,186,858. Beneficient has a 1-year low of $0.50 and a 1-year high of $9.96. The stock has a market capitalization of $11.22 million, a price-to-earnings ratio of -0.10 and a beta of 0.06. The stock’s fifty day moving average is $1.33 and its two-hundred day moving average is $3.05.
Beneficient (NASDAQ:BENF – Get Free Report) last released its quarterly earnings results on Friday, August 14th. The company reported ($0.47) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.06) by $1.59. The firm had revenue of $15.93 million for the quarter, compared to analyst estimates of $10.16 million. As a group, sell-side analysts anticipate that Beneficient will post -9.50 EPS for the current year.
Institutional Trading of Beneficient
An institutional investor recently bought a new position in Beneficient stock. T3 Companies LLC bought a new stake in Beneficient (NASDAQ:BENF – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 43,030 shares of the company’s stock, valued at approximately $59,000. T3 Companies LLC owned approximately 0.28% of Beneficient as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 90.57% of the company’s stock.
About Beneficient
Beneficient (NASDAQ: BENF) is a financial services company that provides liquidity and trust solutions for holders of alternative assets. Its platform is designed to help investors access liquidity from interests in private equity, venture capital, private credit, real estate and other illiquid investments without relying solely on traditional secondary-market sales.
The company’s offerings include the ExAlt Plan, which is structured to allow eligible investors to contribute alternative assets to trusts in exchange for interests that may provide access to liquidity, and AltQuote, a technology-enabled service intended to help investors evaluate potential liquidity options for their holdings.
Featured Stories
- Five stocks we like better than Beneficient
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
- 3 Waste Services Stocks With More Growth Than You Might Expect
- Alphabet’s $400 Billion Sell-Off Could Be the Best AI Buying Window Left in 2026
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png){kind=logo}
